Treatment options for canine cutaneous mast cell tumors - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

Treatment options for canine cutaneous mast cell tumors
You'll likely encounter patients with these neoplasms in your practice. Luckily, many treatment options are available, such as surgery, radiation therapy, and chemotherapy—and new treatments are on the horizon.


VETERINARY MEDICINE


27. Davies DR, Wyatt KM, Jardine JE, et al. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 2004;40:124-130.

28. Grier RL, Di Guardo G, Myers R, et al. Mast cell tumour destruction in dogs by hypotonic solution. J Small Anim Pract 1995;36:385-388.

29. Jaffe MH, Hosgood G, Kerwin SC, et al. Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumours. J Small Anim Pract 2000;41:7-11.

30. Neyens IJ, Kirpensteijn J, Grinwis GC, et al. Pilot study of intraregional deionised water adjunct therapy for mast cell tumours in dogs. Vet Rec 2004;154:90-91.

31. Northrup NC, Roberts RE, Harrell TW, et al. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 2004;40:309-315.

32. Dobson J, Cohen S, Gould S. Treatment of canine mast cell tumours with prednisolone and radiotherapy. Vet Comp Oncol 2004;2:132-141.

33. London CA, Galli SJ, Yuuki T, et al. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol 1999;27:689-697.

34. Ma Y, Longley BJ, Wang X, et al. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms. J Invest Dermatol 1999;112:165-170.

35. Ma Y, Carter E, Wang X, et al. Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cells. J Invest Dermatol 2000;114:392-394.

36. London CA, Hannah AL, Zadovoskaya R, et al. Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 2003;9:2755-2768.


ADVERTISEMENT

Source: VETERINARY MEDICINE,
Click here